TY - JOUR
T1 - Growth of a Human Breast Cancer Cell Line in Serum-free Hormone-supplemented Medium
AU - Allegra, Joseph C.
AU - Lippman, Marc E.
PY - 1978/11
Y1 - 1978/11
N2 - ZR-75-1, a human breast cancer cell line, has been grown in hormone- supplemented medium without serum. The factors required for optimal growth include 17β-estradiol, insulin, transferrin, dexamethasone, and L- triiodothyronine. If estradiol, insulin, or L-triiodothyronine is omitted, cells cease division within 7 days, but viability is retained for at least 14 days. Omission of transferrin leads to cell death within 7 days. The cells have been continuously maintained in this environment without morphological alteration or cessation of growth for more than 5 months. Addition of the anti-estrogen, Tamoxifen (10-6 M), inhibited cells below the growth rate seen when estradiol was omitted from the medium, even when Tamoxifen was added 4 days and two medium changes after the removal of estradiol from the medium, thus suggesting an action of Tamoxifen which may be independent of competition with estradiol. The availability of a human breast cancer cell line that can be propagated in hormone-supplemented medium without serum should aid in the study of the mechanisms by which hormones effect cell growth.
AB - ZR-75-1, a human breast cancer cell line, has been grown in hormone- supplemented medium without serum. The factors required for optimal growth include 17β-estradiol, insulin, transferrin, dexamethasone, and L- triiodothyronine. If estradiol, insulin, or L-triiodothyronine is omitted, cells cease division within 7 days, but viability is retained for at least 14 days. Omission of transferrin leads to cell death within 7 days. The cells have been continuously maintained in this environment without morphological alteration or cessation of growth for more than 5 months. Addition of the anti-estrogen, Tamoxifen (10-6 M), inhibited cells below the growth rate seen when estradiol was omitted from the medium, even when Tamoxifen was added 4 days and two medium changes after the removal of estradiol from the medium, thus suggesting an action of Tamoxifen which may be independent of competition with estradiol. The availability of a human breast cancer cell line that can be propagated in hormone-supplemented medium without serum should aid in the study of the mechanisms by which hormones effect cell growth.
UR - http://www.scopus.com/inward/record.url?scp=0018168638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018168638&partnerID=8YFLogxK
M3 - Article
C2 - 212180
AN - SCOPUS:0018168638
VL - 38
SP - 3823
EP - 3829
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
ER -